Financial reports
10-K
2023 FY
Annual report
28 Mar 24
NT 10-K
Notice of late annual filing
12 Mar 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
10-K
2022 FY
Annual report
31 Mar 23
NT 10-K
Notice of late annual filing
17 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
20 Oct 22
Current reports
8-K
P3 Health Partners Announces Fourth Quarter and Full Year 2023 Results
28 Mar 24
8-K
Amendments to Articles of Incorporation or Bylaws
12 Mar 24
8-K
P3 Health Partners Reaffirms Guidance for 2023 and Announces Guidance for 2024
9 Jan 24
8-K
Entry into a Material Definitive Agreement
13 Nov 23
8-K
Report of Independent Registered Public Accounting Firm
9 Nov 23
8-K
P3 Health Partners Announces Third-Quarter and Year-to-Date 2023 Results
8 Nov 23
8-K
P3 Health Partners Announces Second-Quarter 2023 Results
7 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
26 Jul 23
8-K
P3 Health Partners Announces First-Quarter 2023 Results
10 May 23
8-K
Other Events
25 Apr 23
Registration and prospectus
424B3
Prospectus supplement
21 Nov 23
424B3
Prospectus supplement
21 Nov 23
424B3
Prospectus supplement
13 Nov 23
424B3
Prospectus supplement
13 Nov 23
POS AM
Prospectus update (post-effective amendment)
9 Nov 23
POS AM
Prospectus update (post-effective amendment)
9 Nov 23
S-3
Shelf registration
9 Nov 23
424B3
Prospectus supplement
8 Nov 23
424B3
Prospectus supplement
8 Nov 23
424B3
Prospectus supplement
7 Aug 23
Proxies
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
DEFA14A
Additional proxy soliciting materials
8 Jun 23
DEF 14A
Definitive proxy
8 Jun 23
DEFA14A
Additional proxy soliciting materials
3 Nov 22
DEF 14A
Definitive proxy
3 Nov 22
DEFA14A
Additional proxy soliciting materials
1 Dec 21
DEFA14A
Additional proxy soliciting materials
29 Nov 21
DEFA14A
Additional proxy soliciting materials
29 Nov 21
DEFA14A
Additional proxy soliciting materials
24 Nov 21
Other
EFFECT
Notice of effectiveness
21 Nov 23
EFFECT
Notice of effectiveness
21 Nov 23
EFFECT
Notice of effectiveness
21 Nov 23
CORRESP
Correspondence with SEC
16 Nov 23
UPLOAD
Letter from SEC
16 Nov 23
EFFECT
Notice of effectiveness
15 Jun 23
EFFECT
Notice of effectiveness
15 Jun 23
CORRESP
Correspondence with SEC
12 Jun 23
UPLOAD
Letter from SEC
9 May 23
EFFECT
Notice of effectiveness
10 Nov 22
Ownership
SC 13G/A
AMERIPRISE FINANCIAL INC
27 Feb 24
SC 13G/A
AMERIPRISE FINANCIAL INC
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
LMR Partners LLP
12 Feb 24
4
Thomas Edmunds Price
25 Jan 24
4
MARY A TOLAN
25 Jan 24
4
Mark Thierer
25 Jan 24
4
GREGORY D WASSON
25 Jan 24
4
Lawrence B. Leisure
25 Jan 24
4
Gregory N. Kazarian
25 Jan 24